Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1994; Volume 45,Issue 2
  • You have access
    A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
    W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
    Molecular Pharmacology February 1994, 45 (2) 165-170;
  • You have access
    Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology.
    D T Price, R J Lefkowitz, M G Caron, D Berkowitz and D A Schwinn
    Molecular Pharmacology February 1994, 45 (2) 171-175;
  • You have access
    Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
    H S Blaxall, D R Cerutis, N A Hass, L J Iversen and D B Bylund
    Molecular Pharmacology February 1994, 45 (2) 176-181;
  • You have access
    Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
    P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
    Molecular Pharmacology February 1994, 45 (2) 182-188;
  • You have access
    Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin.
    G Liu, J J Abramson, A C Zable and I N Pessah
    Molecular Pharmacology February 1994, 45 (2) 189-200;
  • You have access
    In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.
    M Garnier, A B Dimchev, N Boujrad, J M Price, N A Musto and V Papadopoulos
    Molecular Pharmacology February 1994, 45 (2) 201-211;
  • You have access
    Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties.
    V Gerzanich, R Anand and J Lindstrom
    Molecular Pharmacology February 1994, 45 (2) 212-220;
  • You have access
    Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
    C K Min, J Owens and G A Weiland
    Molecular Pharmacology February 1994, 45 (2) 221-227;
  • You have access
    Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs.
    T Sakuma, K Masaki, S Itoh, T Yokoi and T Kamataki
    Molecular Pharmacology February 1994, 45 (2) 228-236;
  • You have access
    Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis.
    A Kretz-Rommel and U A Boelsterli
    Molecular Pharmacology February 1994, 45 (2) 237-244;
  • You have access
    Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
    G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
    Molecular Pharmacology February 1994, 45 (2) 245-254;
  • You have access
    Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
    S J Zhu and M L Toews
    Molecular Pharmacology February 1994, 45 (2) 255-261;
  • You have access
    Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
    V N Bochkov, V A Tkachuk, Y S Kuzmenko, Y L Borisova, F R Bühler and T J Resink
    Molecular Pharmacology February 1994, 45 (2) 262-270;
  • You have access
    DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
    Molecular Pharmacology February 1994, 45 (2) 271-276;
  • You have access
    Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
    M P Johnson, R J Loncharich, M Baez and D L Nelson
    Molecular Pharmacology February 1994, 45 (2) 277-286;
  • You have access
    Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
    L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
    Molecular Pharmacology February 1994, 45 (2) 287-293;
  • You have access
    The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
    C J Jensen, N P Gerard, T W Schwartz and U Gether
    Molecular Pharmacology February 1994, 45 (2) 294-299;
  • You have access
    Maitotoxin activates a nonselective cation channel and stimulates Ca2+ entry in MDCK renal epithelial cells.
    P Dietl and H Völkl
    Molecular Pharmacology February 1994, 45 (2) 300-305;
  • You have access
    Binding and functional properties of endothelin receptor subtypes in the human prostate.
    S Kobayashi, R Tang, B Wang, T Opgenorth, P Langenstroer, E Shapiro and H Lepor
    Molecular Pharmacology February 1994, 45 (2) 306-311;
  • You have access
    Release of dopamine via the human transporter.
    A J Eshleman, R A Henningsen, K A Neve and A Janowsky
    Molecular Pharmacology February 1994, 45 (2) 312-316;
  • You have access
    The agonist binding site of the gamma-aminobutyric acid type A channel is not formed by the extracellular cysteine loop.
    J Amin, I M Dickerson and D S Weiss
    Molecular Pharmacology February 1994, 45 (2) 317-323;
  • You have access
    Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits.
    K Masood, C Wu, U Brauneis and F F Weight
    Molecular Pharmacology February 1994, 45 (2) 324-329;
  • You have access
    Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
    K Raynor, H Kong, Y Chen, K Yasuda, L Yu, G I Bell and T Reisine
    Molecular Pharmacology February 1994, 45 (2) 330-334;
  • You have access
    Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
    J Eichler, A Anselment, J L Sussman, J Massoulié and I Silman
    Molecular Pharmacology February 1994, 45 (2) 335-340;
  • You have access
    A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
    P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
    Molecular Pharmacology February 1994, 45 (2) 341-351;
  • You have access
    O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
    M V Relling, J Nemec, E G Schuetz, J D Schuetz, F J Gonzalez and K R Korzekwa
    Molecular Pharmacology February 1994, 45 (2) 352-358;
  • You have access
    Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
    Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
    Molecular Pharmacology February 1994, 45 (2) 359-365;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 45, Issue 2
1 Feb 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics